Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/01/2026 ,inter alia, to consider and approve 1. To consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed BSE that its Board of Directors will meet on Saturday, 3rd January 2026 at 3:00 PM at the registered office in Indore. The Board will consider the appointment of Shailendra Pathak as an Additional Director and Mrs. Neha Sharda as an Independent Director, subject to shareholder approval. It will also consider a related party transaction with Aminova Infusions P. Ltd. and fix the date for an Extra-Ordinary General Meeting (EOGM). Additionally, the Board will take up the resignation of Mrs. Neha Sharma from the post of Company Secretary and the appointment of Mr. Kamlesh Gupta as the new Company Secretary. The intimation is issued under SEBI LODR Regulation 29 by Chairman & Director Sudhir Sethi.
The changes signal a board and key managerial personnel reshuffle — a new Company Secretary and directors are being brought in while the existing Company Secretary steps down. Shareholders should watch for the EOGM outcome, particularly the related party transaction with Aminova Infusions, which may require closer scrutiny.